Smithkline Beecham Corp. v. Synthon Pharmaceuticals, Ltd.
311 F. App'x 323
This text of 311 F. App'x 323 (Smithkline Beecham Corp. v. Synthon Pharmaceuticals, Ltd.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Smithkline Beecham Corp. v. Synthon Pharmaceuticals, Ltd., 311 F. App'x 323 (Fed. Cir. 2008).
Opinion
ON MOTION
ORDER
Upon consideration of Synthon Pharmaceuticals, Ltd. et al.’s unopposed motion to voluntarily dismiss their appeal,
IT IS ORDERED THAT:
(1) The motion is granted.
(2) Each side shall bear its own costs.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
311 F. App'x 323, Counsel Stack Legal Research, https://law.counselstack.com/opinion/smithkline-beecham-corp-v-synthon-pharmaceuticals-ltd-cafc-2008.